Company / Operating Income
Solventum Operating Income History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
$2.2B
FY2025
5-year range
$1.0B / $2.2B
FY2022-FY2025
Trend
+110.5%
vs FY2024
Sector context
#20 of 156
Health Care
What the data says
Solventum's operating income of $2.2B is higher than 87% of companies in the Health Care sector (FY2025). Operating Income returned to growth in FY2025 after 2 years of decline, reaching $2.2B.
Based on SEC 10-K filings.
$2.2B in FY2025 with a 3-year CAGR of +8.8%. Top quartile in the Health Care sector.
Improved from $1.7B to $2.2B over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 156This company $2.2B Sector average $733.1M
▼
+197.5% above sector average
Key checks
Key Insights
- 3-year CAGR of +8.8%, indicating consistent growth.
- In FY2025, operating income increased 110.5% year-over-year.
- Ranks #20 out of 156 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.2B | +110.5% |
| FY2024 | $1.0B | -38.8% |
| FY2023 | $1.7B | -0.1% |
| FY2022 | $1.7B | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026